Publications
5808 Results
- Journal / Conference
- Journal of the National Cancer Institute 87(16):1254-1256
- Year
- 1995
- Research Committee(s)
- Breast
- Study Number(s)
- SWOG-8294 (INT-0011) (EST-1180)
Accumulation of p53 protein as a possible predictor of response to adjuvant combination chemotherapy with cyclophosphamide, methotrexate, fluorouracil, and prednisone for breast cancer.
- Journal / Conference
- Journal of the American Academy of Dermatology 33(3):532-534
- Year
- 1995
- Research Committee(s)
- Melanoma
- Study Number(s)
- SWOG-8393 (INT-0013)
A centimeter here, a centimeter there: Does it matter?
- Journal / Conference
- Blood 86(10)(Suppl.1)(#1061):269a
- Year
- 1995
- Research Committee(s)
- Leukemia
- Study Number(s)
- SWOG-9031
MDR1 expression is highly predictive for achievement of complete remission (CR) in acute myeloid leukemia (AML) in the elderly: A Southwest Oncology Group study.
- Journal / Conference
- AUA Update Series (Lesson 29) 14:234-240
- Year
- 1995
- Research Committee(s)
- Genitourinary
Immunotherapy of superficial bladder carcinoma.
- Journal / Conference
- Journal of Clinical Oncology 13:797-798
- Year
- 1995
- Research Committee(s)
- Lung
- Study Number(s)
- SWOG-9038
The price of success.
- Journal / Conference
- Leukemia 9(3):535(#O31)
- Year
- 1995
- Research Committee(s)
- Leukemia
- Study Number(s)
- SWOG-8600, SWOG-9007
Multidrug resistance (MDR1) expression and function in acute myeloid leukemia (AML) in the elderly: MDR1 and secondary AML status are independent predictors of complete remission (CR).
- Journal / Conference
- Blood 86(10)(Suppl.1)(#2902):729a
- Year
- 1995
- Research Committee(s)
- Leukemia
- Study Number(s)
- SWOG-9129 (INT-0129)
Correlation of PML-RARa mRNA type with pretreatment clinical characteristics and achievement of complete remission (CR) in acute promyelocytic leukemia (APL): An Intergroup Laboratory study.
- Journal / Conference
- Controlled Clinical Trials 16:4S-29S
- Year
- 1995
Functions and organization of coordinating centers for multicenter studies.
- Journal / Conference
- Blood 86(10)(Suppl.1)(#2414):607a
- Year
- 1995
- Research Committee(s)
- Leukemia
- Study Number(s)
- SWOG-9108 (CALGB-9011)
Fludarabine induces a high complete remission rate in previously untreated patients with active chronic lymphocytic leukemia (CLL). A randomized inter-group study.
- Journal / Conference
- Recent Advances in Clinical Trial Design and Analysis :113-124
- Year
- 1995
- Research Committee(s)
- Myeloma
- Study Number(s)
- SWOG-8229/30